Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Nektar Therapeutics

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Nektar Therapeutics is a biopharmaceutical company developing innovative therapies in immuno-oncology and immunology using its proprietary drug platform technologies. The company focuses on polymer conjugate technology to modify and optimize drug candidates. Nektar has multiple clinical-stage programs aimed at treating cancer and autoimmune diseases.